脓毒症心肌病的研究进展  

Research progress on septic cardiomyopathy

作　　者：张晓航 申丽旻[2] 李丹丹 Zhang Xiaohang;Shen Limin;Li Dandan(Graduate School,Hebei Medical University,Shijiazhuang 050000,China;Intensive Care Unit of Hebei General Hospital,Shijiazhuang 050051,China)

机构地区：[1]河北医科大学研究生院,石家庄050000 [2]河北省人民医院重症医学科,石家庄050051

出　　处：《中国医师杂志》2024年第5期789-792,共4页Journal of Chinese Physician

基　　金：河北省政府资助卫生健康优秀人才与公立医院高质量发展项目(13000022P00DE34100247)。

摘　　要：脓毒症心肌病是脓毒症的常见并发症之一,是一种可逆的心肌功能障碍,主要表现为左心室扩张和射血分数降低,通常在7~10 d内恢复。脓毒症心肌病可能因诊断不及时或治疗不规范,导致患者的病死率增高。本文总结了近年来专家学者对脓毒症心肌病新的认知,包括定义、临床表现、发病机制、诊断、治疗等内容,以期为临床上脓毒症心肌病的诊治提供一些思路。Septic cardiomyopathy is one of the common complications of sepsis,which is a reversible myocardial dysfunction characterized by left ventricular dilation and decreased ejection fraction,typically recovering within 7-10 days.Septic cardiomyopathy may increase the mortality rate of patients due to delayed diagnosis or non-standard treatment.In order to provide some ideas for the diagnosis and treatment of sepsis cardiomyopathy in clinical practice,this article summarizes the new understanding of sepsis cardiomyopathy by experts and scholars in recent years,including definition,clinical manifestations,pathogenesis,diagnosis,treatment,etc.

关 键 词：脓毒症 心肌疾病 

分 类 号：R459.7[医药卫生—急诊医学] R542.2[医药卫生—治疗学]